Table 1.
The item-specific accuracy of data extraction by Claude
| Item ID | Item | Total number | Correct number | Wrong number | Correct extraction rate | 95% Confidence Interval | |
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| 1.1 | Study ID | 10 | 10 | 0 | 100.00% | ||
| 1.2 | Aim of study | 10 | 10 | 0 | 100.00% | ||
| 1.3 | Design | 10 | 9 | 1 | 90.00% | 55.50% | 99.75% |
| 1.4 | Country | 10 | 9 | 1 | 90.00% | 55.50% | 99.75% |
| 1.5 | Unit of allocation | 10 | 10 | 0 | 100.00% | ||
| 1.6 | Start date | 10 | 10 | 0 | 100.00% | ||
| 1.7 | End date | 10 | 10 | 0 | 100.00% | ||
| 1.8 | Duration of participation | 10 | 9 | 1 | 90.00% | 55.50% | 99.75% |
| 1.9 | Ethical approval needed/obtained for study | 10 | 10 | 0 | 100.00% | ||
| 2.1 | Population description | 10 | 10 | 0 | 100.00% | ||
| 2.2 | Setting | 10 | 7 | 3 | 70.00% | 34.75% | 93.33% |
| 2.3 | Inclusion criteria | 10 | 10 | 0 | 100.00% | ||
| 2.4 | Exclusion criteria | 10 | 10 | 0 | 100.00% | ||
| 2.5 | Method of recruitment of participants | 10 | 10 | 0 | 100.00% | ||
| 2.6 | Informed consent obtained | 10 | 10 | 0 | 100.00% | ||
| 2.7 | Total no. randomized | 10 | 10 | 0 | 100.00% | ||
| 2.8 | Clusters | 10 | 10 | 0 | 100.00% | ||
| 2.9 | Baseline imbalances | 10 | 8 | 2 | 80.00% | 44.39% | 97.48% |
| 2.10 | Subgroups measured | 10 | 10 | 0 | 100.00% | ||
| 3.1.1 | Intervention name | 22 | 22 | 0 | 100.00% | ||
| 3.1.2 | Assessed for eligibility | 22 | 4 | 18 | 18.18% | 5.19% | 40.28% |
| 3.1.3 | Excluded | 22 | 2 | 20 | 9.09% | 1.12% | 29.16% |
| 3.1.4 | Randomized | 22 | 22 | 0 | 100.00% | ||
| 3.1.5 | Lost to follow-up | 22 | 13 | 9 | 59.09% | 36.35% | 79.29% |
| 3.1.6 | Analyzed | 22 | 18 | 4 | 81.82% | 59.72% | 94.81% |
| 3.1.7 | Excluded from analysis | 22 | 11 | 11 | 50.00% | 28.22% | 71.78% |
| 3.1.8 | Age | 22 | 21 | 1 | 95.45% | 77.16% | 99.88% |
| 3.1.9 | Female | 22 | 22 | 0 | 100.00% | ||
| 3.1.10 | Race/Ethnicity | 22 | 22 | 0 | 100.00% | ||
| 3.1.11 | BMI | 22 | 22 | 0 | 100.00% | ||
| 3.1.12 | Severity of illness | 22 | 22 | 0 | 100.00% | ||
| 3.1.13 | Co-morbidities | 22 | 22 | 0 | 100.00% | ||
| 4.1.1 | Outcome name | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 4.1.2 | Outcome definition | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 4.1.3 | Outcome measurement tool | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 4.1.4 | Unit of measurement | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 4.1.5 | Range of measurement | 59 | 59 | 0 | 100.00% | ||
| 4.1.6 | Is outcome/tool validated | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 4.1.7 | Evaluation type | 59 | 59 | 0 | 100.00% | ||
| 4.1.8 | Power | 59 | 59 | 0 | 100.00% | ||
| 4.1.9 | Analysis Method | 59 | 57 | 2 | 96.61% | 88.29% | 99.59% |
| 5.1.1 | Outcome name | 58 | 58 | 0 | 100.00% | ||
| 5.1.2 | Intervention and comparison | 58 | 58 | 0 | 100.00% | ||
| 5.1.3 | Outcome type | 55 | 55 | 0 | 100.00% | ||
| 5.1.4 | Effect | 58 | 58 | 0 | 100.00% | ||
| 5.1.5 | LCI (Lower Confidence Interval) | 55 | 55 | 0 | 100.00% | ||
| 5.1.6 | UCI (Upper Confidence Interval) | 55 | 54 | 1 | 98.18% | 90.28% | 99.95% |
| 5.1.7 | Discrete trend | 56 | 56 | 0 | 100.00% | ||
| 5.1.8 | No. with event in IG (Intervention Group) | 57 | 57 | 0 | 100.00% | ||
| 5.1.9 | Total in group in IG | 57 | 57 | 0 | 100.00% | ||
| 5.1.10 | No. with event in CG (Control Group) | 57 | 57 | 0 | 100.00% | ||
| 5.1.11 | Total in group in CG | 57 | 57 | 0 | 100.00% | ||
| 5.1.12 | Missing participants | 56 | 47 | 9 | 83.93% | 71.67% | 92.38% |
| 5.1.13 | Participants moved from another group | 56 | 51 | 5 | 91.07% | 80.38% | 97.04% |
| 5.1.14 | Time points measured | 56 | 56 | 0 | 100.00% | ||
| 5.1.15 | Subgroup | 55 | 55 | 0 | 100.00% | ||
| 6.1 | Study funding sources | 10 | 10 | 0 | 100.00% | ||
| 6.2 | Possible conflicts of interest | 10 | 10 | 0 | 100.00% | ||